Early discharge in selected patients with low-grade renal trauma.


Journal

World journal of urology
ISSN: 1433-8726
Titre abrégé: World J Urol
Pays: Germany
ID NLM: 8307716

Informations de publication

Date de publication:
Apr 2020
Historique:
received: 21 04 2019
accepted: 21 06 2019
pubmed: 30 6 2019
medline: 29 1 2021
entrez: 30 6 2019
Statut: ppublish

Résumé

The aim of this study was to assess whether early discharge could be non-inferior to inpatient management in selected patients with low-grade renal trauma (AAST grades 1-3). A retrospective national multicenter study was conducted including all patients who presented with renal trauma at 17 hospitals between 2005 and 2015. Exclusion criteria were iatrogenic and AAST grades 4 and 5 trauma, non-conservative initial management, Hb < 10 g/dl or transfusion within the first 24 h, and patients with concomitant injuries. Patients were divided into two groups according to the length of hospital stay: ≤ 48 h (early discharge), and > 48 h (inpatient). The primary outcome was "Intervention" defined as any interventional procedure needed within the first 30 days. A Stabilized Inverse Probability of Treatment Weighting (SIPTW) propensity score based binary response model was used to estimate risk difference. Out of 1764 patients with renal trauma, 311 were included in the analysis (44 in the early discharge and 267 in the inpatient group). In the early discharge group, only one patient required an intervention within the first 30 days vs. 10 in the inpatient group (3.7% vs. 5.2%; p = 0.99). Adjusted analysis using SIPTW propensity score showed a risk difference of - 2.8% [- 9.3% to + 3.7%] of "interventions" between the two groups meeting the non-inferiority criteria. In a highly selected cohort, early discharge management of low-grade renal trauma was not associated with an increased risk of early "intervention" compared to inpatient management. Further prospective randomized controlled trials are needed to confirm these findings.

Identifiants

pubmed: 31254097
doi: 10.1007/s00345-019-02855-y
pii: 10.1007/s00345-019-02855-y
doi:

Types de publication

Comparative Study Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

1009-1015

Investigateurs

Lucas Freton (L)
Lucie-Marie Scailteux (LM)
Marine Hutin (M)
Jonathan Olivier (J)
Quentin Langouet (Q)
Marina Ruggiero (M)
Ines Dominique (I)
Clémentine Millet (C)
Sébastien Bergerat (S)
Paul Panayatopoulos (P)
Reem Betari (R)
Xavier Matillon (X)
Ala Chebbi (A)
Thomas Caes (T)
Pierre-Marie Patard (PM)
Nicolas Szabla (N)
Nicolas Brichart (N)
Axelle Boehm (A)
Laura Sabourin (L)
Kerem Guleryuz (K)
Charles Dariane (C)
Cédric Lebacle (C)
Jérome Rizk (J)
Alexandre Gryn (A)
François-Xavier Madec (FX)
François-Xavier Nouhaud (FX)
Xavier Rod (X)
Gaelle Fiard (G)
Benjamin Pradere (B)
Benoit Peyronnet (B)

Références

J Trauma. 2011 May;70(5):1229-33
pubmed: 21610437
Br J Urol. 1996 Apr;77(4):512-7
pubmed: 8777609
J Trauma Acute Care Surg. 2018 Mar;84(3):418-425
pubmed: 29298242
Arch Surg. 2008 Oct;143(10):972-6; discussion 977
pubmed: 18936376
Am J Surg. 2017 Sep;214(3):402-406
pubmed: 28610936
J Trauma Acute Care Surg. 2016 Mar;80(3):466-71
pubmed: 26713978
Semin Urol. 1995 Feb;13(1):77-82
pubmed: 7597357
JAMA Surg. 2013 Oct;148(10):924-31
pubmed: 23945834
Curr Opin Crit Care. 2010 Dec;16(6):596-601
pubmed: 20838218
J R Army Med Corps. 2012 Jun;158(2):85-95
pubmed: 22860496
Crit Care. 2013 Sep 03;17(5):R185
pubmed: 24004931
Urology. 2014 Jul;84(1):62-7
pubmed: 24821469
Biomed Res Int. 2015;2015:124969
pubmed: 25629032
J Urol. 2014 Aug;192(2):327-35
pubmed: 24857651
Eur Urol Focus. 2019 Mar;5(2):290-300
pubmed: 28753890
J Pediatr Surg. 2014 Jun;49(6):1004-8; discussion 1008
pubmed: 24888852
Eur J Trauma Emerg Surg. 2018 Dec;44(6):883-887
pubmed: 29209737
Haematologica. 2015 Aug;100(8):1045-50
pubmed: 26001789
Urology. 2018 May;115:92-95
pubmed: 29203185

Auteurs

Lucas Freton (L)

Urology, University of Rennes, Rennes, France. lucas.freton@gmail.com.
Service d'urologie, Hopital Pontchaillou, 2 rue Henri Le Guilloux, 35000, Rennes, France. lucas.freton@gmail.com.

Lucie-Marie Scailteux (LM)

Univ Rennes, CHU Rennes, REPERES [(Recherche en Pharmaco-épidémiologie et Recours aux Soins)], EA 7449, 35000, Rennes, France.

Marine Hutin (M)

Urology, University of Montpellier, Montpellier, France.

Jonathan Olivier (J)

Urology, University of Lille, Lille, France.

Quentin Langouet (Q)

Urology, University of Tours, Tours, France.

Marina Ruggiero (M)

Urology, University of Paris Sud, CHU Bicetre, Paris, France.

Ines Dominique (I)

Urology, University of Lyon, Lyon, France.

Clémentine Millet (C)

Urology, University of Clermont-Ferrand, Clermont-Ferrand, France.

Sébastien Bergerat (S)

Urology, University of Strasbourg, Strasbourg, France.

Paul Panayatopoulos (P)

Urology, University of Angers, Angers, France.

Reem Betari (R)

Urology, University of Amiens, Amiens, France.

Xavier Matillon (X)

Urology, University of Lyon, Lyon, France.

Ala Chebbi (A)

Urology, University of Rouen, Rouen, France.

Thomas Caes (T)

Urology, University of Lille, Lille, France.

Pierre-Marie Patard (PM)

Urology, University of Toulouse, Toulouse, France.

Nicolas Szabla (N)

Urology, University of Caen, Caen, France.

Nicolas Brichart (N)

Urology, University of Orléans, Orléans, France.

Axelle Boehm (A)

Urology, University of Tours, Tours, France.

Laura Sabourin (L)

Urology, University of Clermont-Ferrand, Clermont-Ferrand, France.

Kerem Guleryuz (K)

Urology, University of Caen, Caen, France.

Charles Dariane (C)

Urology, University of Paris Descartes, Paris, France.

Cédric Lebacle (C)

Urology, University of Paris Sud, CHU Bicetre, Paris, France.

Jérome Rizk (J)

Urology, University of Lille, Lille, France.

Alexandre Gryn (A)

Urology, University of Toulouse, Toulouse, France.

François-Xavier Madec (FX)

Urology, University of Nantes, Nantes, France.

François-Xavier Nouhaud (FX)

Urology, University of Rouen, Rouen, France.

Xavier Rod (X)

Urology, University of Nantes, Nantes, France.

Emmanuel Oger (E)

Univ Rennes, CHU Rennes, REPERES [(Recherche en Pharmaco-épidémiologie et Recours aux Soins)], EA 7449, 35000, Rennes, France.

Gaelle Fiard (G)

Urology, University of Grenoble, Grenoble, France.

Karim Bensalah (K)

Urology, University of Rennes, Rennes, France.

Benjamin Pradere (B)

Urology, University of Tours, Tours, France.

Benoit Peyronnet (B)

Urology, University of Rennes, Rennes, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH